
Not a breakup text, just a cooler tone
TD Cowen took a tiny bite out of Aptiv’s price target, trimming it from $93 to $90. The important part? The firm still says Buy, which is analyst-speak for: “We still like the stock, we just don’t love it quite as much today.”
Why you should care
Aptiv sits in the auto-tech lane, building safer, greener, more connected mobility systems. So when analysts keep nudging targets around, it can sway sentiment on a name that already has plenty of moving parts — EV demand, auto production, and all the usual industry drama.
The street is still broadly in the corner
TD Cowen wasn’t alone in tweaking the story. HSBC recently cut its target on Aptiv, while JPMorgan bumped its own higher. Translation: the analysts are still arguing over the price tag, but nobody’s exactly heading for the exits.
- TD Cowen: target cut to $90, rating stays Buy
- HSBC: target cut to $81.32, still Buy
- JPMorgan: target raised to $105, rated Overweight
Big picture
For you, this is less “something is broken” and more “the optimism bar just moved a little lower.” Aptiv still has Wall Street support, but the target drift hints the easy upside story may be getting a bit more complicated.
